Merck Kgaa, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SODIUM ACETATE TRIHYDRATE, with a corresponding US DMF Number 23802.
Remarkably, this DMF maintains an Active status since its submission on May 13, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 05, 2016, and payment made on May 05, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II